241 related articles for article (PubMed ID: 33040226)
1. Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis.
Hammer HB; Michelsen B; Sexton J; Uhlig T; Provan SA
Clin Rheumatol; 2021 May; 40(5):1739-1749. PubMed ID: 33040226
[TBL] [Abstract][Full Text] [Related]
2. Fatigue Is Not Associated With Objective Assessments of Inflammation During Tocilizumab Treatment of Patients With Rheumatoid Arthritis.
Hammer HB; Agular B; Terslev L
ACR Open Rheumatol; 2022 Mar; 4(3):202-208. PubMed ID: 34806341
[TBL] [Abstract][Full Text] [Related]
3. Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients.
Hammer HB; Uhlig T; Kvien TK; Lampa J
Arthritis Care Res (Hoboken); 2018 May; 70(5):703-712. PubMed ID: 28805018
[TBL] [Abstract][Full Text] [Related]
4. Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study.
Hammer HB; Michelsen B; Provan SA; Sexton J; Lampa J; Uhlig T; Kvien TK
Arthritis Care Res (Hoboken); 2020 Jan; 72(1):27-35. PubMed ID: 30474932
[TBL] [Abstract][Full Text] [Related]
5. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
6. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
Nordal HH; Brokstad KA; Solheim M; Halse AK; Kvien TK; Hammer HB
Arthritis Res Ther; 2017 Jan; 19(1):3. PubMed ID: 28081709
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Fatigue in Rheumatoid Arthritis Patients in Remission or in a Low Disease Activity State.
Olsen CL; Lie E; Kvien TK; Zangi HA
Arthritis Care Res (Hoboken); 2016 Jul; 68(7):1043-8. PubMed ID: 26555897
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy.
Provan SA; Michelsen B; Sexton J; Uhlig T; Hammer HB
RMD Open; 2020 Nov; 6(3):. PubMed ID: 33214326
[TBL] [Abstract][Full Text] [Related]
9. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
10. Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation.
Hammer HB; Kvien TK; Terslev L
Clin Exp Rheumatol; 2017; 35(6):959-965. PubMed ID: 28516887
[TBL] [Abstract][Full Text] [Related]
11. Fatigue in rheumatoid arthritis reflects pain, not disease activity.
Pollard LC; Choy EH; Gonzalez J; Khoshaba B; Scott DL
Rheumatology (Oxford); 2006 Jul; 45(7):885-9. PubMed ID: 16449363
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission.
Hammer HB; Jensen Hansen IM; Järvinen P; Leirisalo-Repo M; Ziegelasch M; Agular B; Terslev L
Rheumatol Adv Pract; 2021; 5(2):rkab030. PubMed ID: 34131623
[TBL] [Abstract][Full Text] [Related]
13. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
[TBL] [Abstract][Full Text] [Related]
14. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
Gerber LH; Furst G; Yarboro C; el-Gabalawy H
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
[TBL] [Abstract][Full Text] [Related]
15. Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment.
Holten K; Paulshus Sundlisater N; Lillegraven S; Sexton J; Nordberg LB; Moholt E; Hammer HB; Uhlig T; Kvien TK; Haavardsholm EA; Aga AB
Ann Rheum Dis; 2022 Mar; 81(3):344-350. PubMed ID: 34389605
[TBL] [Abstract][Full Text] [Related]
16. Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis.
Hammer HB; Hansen I; Järvinen P; Leirisalo-Repo M; Ziegelasch M; Agular B; Terslev L
Scand J Rheumatol; 2021 Jul; 50(4):262-270. PubMed ID: 33464147
[No Abstract] [Full Text] [Related]
17. The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.
Hammer HB; Fagerhol MK; Wien TN; Kvien TK
Arthritis Res Ther; 2011; 13(5):R178. PubMed ID: 22029973
[TBL] [Abstract][Full Text] [Related]
18. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
[TBL] [Abstract][Full Text] [Related]
19. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
[TBL] [Abstract][Full Text] [Related]
20. DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs.
Pukšić S; Bolton-King P; Sexton J; Michelsen B; Kvien TK; Berner Hammer H
RMD Open; 2018; 4(2):e000765. PubMed ID: 30487999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
